Clinical trials in Iasi – page 10

225 clinical trials in Iasi, Romania across 6 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in RomaniaStudii.Clinice.ro

Iasi at a glance

225

clinical trials

Research sites6

Quick filters

225 trials in Iasi

Open in trial search

Plasma cell myeloma

Recruiting

Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid
Sponsor:Celgene Corp.

Contact Research Centre

Obesity+1

Not yet recruiting

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Investigational

Phase 3 Double‑Blind Study of Olatorepatide for Weight Loss in Adults with Overweight or Obesity Without Diabetes

Investigational

Romania

Participants:18–64 years · 65+ years
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Type 2 diabetes mellitus+2

Not yet recruiting

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational

Efficacy and Safety of Olatorepatide in Adults with Overweight or Obesity and Type 2 Diabetes

Investigational

Romania

Participants:18–64 years · 65+ years
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Systemic lupus erythematosus+1

Not yet recruiting

Randomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis

Investigational

Randomized Placebo‑Controlled Trial of Cenerimod for Efficacy and Safety in Adults with Systemic Lupus Erythematosus and Active Lupus Nephritis

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Cenerimod
Sponsor:Viatris Innovation GmbH

Contact Research Centre

Asthma

Not yet recruiting

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo

Asthma in adults: beclometasone dipropionate, formoterol fumarate dihydrate, and glycopyrronium bromide compared with beclometasone dipropionate and formoterol fumarate dihydrate

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Beclometasone Dipropionate
Sponsor:Chiesi Farmaceutici S.p.A.

Contact Research Centre

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational

Romania

Participants:18–64 years · 65+ years
Sponsor:Amgen Inc.

Contact Research Centre

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Tocilizumab
Sponsor:Dr Reddy's Laboratories Limited

Contact Research Centre

HIV infection

Not yet recruiting

Safety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1

Registered drugNo placebo

Safety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Bictegravir
Sponsor:Gilead Sciences Inc.

Contact Research Centre

Clear cell renal cell carcinoma+2

Not yet recruiting

Phase 1/2 Study of pumitamig Alone or Combined with ipilimumab or cabozantinib in Patients with Advanced Renal Cell Carcinoma

Registered drugNo placebo

Phase 1/2 Study of pumitamig Alone or Combined with ipilimumab or cabozantinib in Patients with Advanced Renal Cell Carcinoma

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Cabozantinib
Sponsor:Bristol-Myers Squibb Services Unlimited Company

Contact Research Centre

Idiopathic pulmonary fibrosis

Not yet recruiting

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Deupirfenidone
Sponsor:Puretech Lyt 100 Inc.

Contact Research Centre

Breast cancer+2

Not yet recruiting

Efficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer

Registered drug

Efficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Letrozole
Sponsor:Laboratorios Farmaceuticos Rovi S.A.

Contact Research Centre

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Iasi

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on multiple cancer types, including prostate, gastric, lung, and breast cancer. Studies evaluate novel therapies and treatment combinations to improve patient outcomes.

Metastatic Prostate Cancer Treatment
HER2-positive Gastric Cancer Therapy
Advanced Lung Cancer Solutions
Breast Cancer Management

Research emphasizes personalized treatment approaches and targeted therapies for specific cancer subtypes.

02 Cardiovascular Studies

Comprehensive research into heart disease prevention and treatment, with trials examining new approaches to reduce cardiovascular risks and improve patient outcomes.

Heart Failure Prevention
Cardiovascular Disease Management
Lipoprotein Studies

Investigations focus on innovative therapeutic combinations and preventive strategies.

03 Dermatology Research

Studies evaluating treatments for chronic skin conditions, particularly focusing on psoriasis and related disorders.

Plaque Psoriasis Treatment
Psoriatic Arthritis Management
Long-term Safety Studies

Research aims to develop more effective therapies for moderate to severe skin conditions.

04 Neurological Disorders

Clinical trials investigating treatments for Alzheimer's disease and associated conditions, focusing on innovative therapeutic approaches.

Alzheimer's-related Psychosis
Cognitive Function Studies

Research emphasizes symptom management and quality of life improvements.

Back to Romania All countries